Flavored E-Cigarettes and Adolescent Health

Innovation by Mass General for Children
Jul.21.2022

Pediatricians have seen firsthand their patients struggle with nicotine addiction due to e-cigarette use and are now calling on the U.S. Food and Drug Administration to take strong action to curb youth use of these addictive products. A white paper led by Jonathan Winickoff, MD, MPH, pediatrician at Mass General for Children and director of Pediatric Research at the Massachusetts General Hospital Tobacco Research & Treatment Center, and endorsed by pediatricians and pediatric tobacco control experts from across the nation summarizes the serious, continued threat flavored tobacco products cause to youth and describes the deliberate product design and marketing tactics used by e-cigarette companies to make their products more appealing to children and adolescents.

 

Swift action is needed to address e-cigarette use among young people. Winickoff and his co-authors here offer critical recommendations, including marketing restrictions and flavored tobacco product bans, that have been endorsed by more than 200 U.S. pediatricians to protect children from the dangers of e-cigarettes.

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

Wales’ 30K Illegal Vape Seizures in 2024 Mask Just 12% Enforcement Efficacy
Wales’ 30K Illegal Vape Seizures in 2024 Mask Just 12% Enforcement Efficacy
UK authorities in Wales seized over 30,000 illegal vaping products in 2024, with Newport alone contributing a third of the total—marking a 173% year-on-year surge in confiscations. Industry leaders are now pushing for a licensing framework for retail and distribution to counter potential illicit market growth driven by the upcoming disposable vape ban.
Apr.24 by 2FIRSTS.ai
Malaysia to Remove Unregistered Vaping Products by October, Says Health Ministry
Malaysia to Remove Unregistered Vaping Products by October, Says Health Ministry
Malaysia’s Ministry of Health expects to complete the registration and approval process for vaping products by October. Products not included in the official registry will be banned from sale.
Jun.11 by 2FIRSTS.ai
U.S. ITC Reopens PAX Labs Case Against STIIIZY, ALD; Domestic Industry Status at Center of Dispute
U.S. ITC Reopens PAX Labs Case Against STIIIZY, ALD; Domestic Industry Status at Center of Dispute
The U.S. International Trade Commission (ITC) has announced a partial review of a key ruling in PAX Labs' patent infringement case against STIIIZY and ALD, focusing on whether the economic prong of the "domestic industry" requirement was properly assessed. While the commission previously found some of PAX's patents valid and infringed, it ruled that PAX had not demonstrated sufficient U.S. economic investment to establish a domestic industry, and therefore did not find a violation.
May.20 by 2FIRSTS.ai
South Korean Social Organizations Support Lawsuits Against Tobacco Companies and Call for the Establishment of a Smoking Damage Fund
South Korean Social Organizations Support Lawsuits Against Tobacco Companies and Call for the Establishment of a Smoking Damage Fund
The Korea Association of the Elderly Strongly Backs the National Health Insurance Corporation’s Tobacco Litigation, Calling on Tobacco Companies to Establish a Smoking Damage Fund to Fulfill Their Social Responsibilities.
Jun.11 by 2FIRSTS.ai
MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
A study by Massachusetts General Hospital found that the oral smoking cessation drug varenicline significantly improves e-cigarette quit rates among young people aged 16 to 25. In a 12-week trial, 50% of participants in the varenicline group successfully quit vaping, compared to just 14% in the placebo group. After six months, 28% of those in the treatment group remained vape-free.
Apr.24 by 2FIRSTS.ai
RELX Technology Q1 2025 Financial Report: Revenue Rises 46.5% YoY to $110 Million, Slips 0.6% from Previous Quarter
RELX Technology Q1 2025 Financial Report: Revenue Rises 46.5% YoY to $110 Million, Slips 0.6% from Previous Quarter
RELX Technology reported net revenue of RMB 810 million (US $110 million) for Q1 2025, down 0.6% quarter-over-quarter but up 46.5% year-over-year. On a non-GAAP basis, adjusted net profit for the quarter was RMB 250 million (US $34.6 million), a 0.2% decrease from the previous quarter and a 21.0% increase from a year earlier.
May.16 by 2FIRSTS.ai